Oppenheimer reiterates ServiceNow stock rating on healthy demand By Investing.com

Oppenheimer reiterated an Outperform rating on ServiceNow with a $130 price target, implying about 27% upside from the current $102.13 share price. Customer interviews suggest enterprise IT spending and AI-related demand remain healthy, supporting a stronger second half of 2026 and possible reacceleration in 2027. The article also notes shareholder approval of a 38 million-share increase to the 2021 equity incentive plan and multiple other bullish analyst calls.

Analysis

The cleaner read-through is not “AI enthusiasm” but budget durability: if enterprise buyers are still protecting software spend while moderating hiring, workflow platforms gain share as the default substitute for incremental labor. That is a second-order positive for NOW because it ties monetization to operational efficiency initiatives, not discretionary innovation budgets, which tends to make demand more resilient through a slowdown and less cyclical than point-solution AI names.

The market may still be underappreciating the operating leverage embedded in this setup. If AI agents reduce low-end support headcount, the near-term headline risk is weaker seat growth, but the larger effect is a reallocation of spend from labor to software orchestration, governance, and control layers — exactly where NOW is positioning. That creates a multi-quarter conversion window where customer urgency rises before budgets are fully normalized, which can support bookings even if realized revenue inflects later.

A more interesting angle is competitive: the vendor most likely to lose share is not another ITSM incumbent, but fragmented internal tooling, services-heavy integrators, and niche AI workflow vendors that lack governance credibility. If customers are worried about agent risk, they will prefer platforms with auditability and controls, which should tighten NOW’s moat and compress the addressable market for low-trust copilots. The 38M-share authorization is a mild overhang, but it also signals management confidence if repurchases offset dilution over the next 12-18 months.

The contrarian risk is that the AI cycle could become a “pilot tax” rather than a revenue driver: lots of demos, slower monetization, and a longer gap between enthusiasm and renewal uplift. If CIOs decide to wait for a more mature agent stack, the current multiple rerating may stall for 1-2 quarters. The key catalyst is whether the next two earnings prints show expansion in AI-related attach rates and not just pipeline rhetoric.

Key Decisions for Investors

• Long NOW on a 3-6 month horizon via equity or call spreads; target a re-rating toward the $120-130 consensus band if enterprise spend remains intact and AI attach improves. Risk: near-term multiple compression if bookings are strong but conversion lags.
• Pair trade: long NOW / short a basket of lower-trust AI workflow or services-heavy software names over 2-4 quarters. The thesis is governance and control layers outperform speculative agent-adjacent spend as buyers prioritize auditability.
• Buy NOW on any post-earnings drawdown >8% unless the guide implies a genuine demand break. Use a defined-risk structure: sell put spreads 10-15% below spot to express conviction while limiting downside.
• Monitor for evidence of headcount substitution turning into deployment acceleration; if management quantifies higher automation ROI, add to position ahead of the next two quarter cycle. If not, trim 25-30% into strength because the AI monetization gap can linger.
• Avoid chasing broad software beta; prefer NOW as a relative-strength long within enterprise software if macro weakens, since its demand mix is more budget-protection oriented than growth-discretionary.